Comments
Loading...
Altimmune (ALT) Forecast
NewsEarningsAltimmune (ALT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAltimmune (NASDAQ:ALT) Stock Quotes, Forecast and News Summary
Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Altimmune (ALT) stock?
You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.
Who are Altimmune (ALT) competitors?
Other companies in Altimmune’s space includes: KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Upstream Bio (NASDAQ:UPB) and Sage Therapeutics (NASDAQ:SAGE).
What is the forecast, or price target, for Altimmune (ALT) stock?
Altimmune has a consensus price target of $22.00.
What is the current price for Altimmune (ALT)?
The stock price for Altimmune (NASDAQ: ALT) is $6.55 last updated February 21, 2025 at 10:44 AM EST.
Does Altimmune (ALT) pay a dividend?
There are no upcoming dividends for Altimmune.
When is Altimmune (NASDAQ:ALT) reporting earnings?
Altimmune’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Altimmune (ALT) going to split?
There is no upcoming split for Altimmune.
What sector and industry does Altimmune (ALT) operate in?
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.